Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
VanEck Pharmaceutical ETF (PPH)
USD108.78
-0.02 (-0.02%)
NASDAQ USD US Equity
NAV
USD 108.76
+0.02% vs NAV
as of 2026-07-13
AUM
USD 944.89M
TER
0.36%
Yield (TTM)
2.00%
Distribution
Distributing · Quarterly
52-week range
82.58 – 111.70
Holdings
27
Issuer
VanEck
About this ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
ISIN
US92189F6925
Issuer
VanEck
Domicile
US
Inception
2011-12-20
Asset class
Equity
Price
Top 10 holdings
| Eli Lilly & Co LLY | 20.17% |
| Novartis Ag NVS | 10.51% |
| Merck & Co Inc MRK | 9.52% |
| Novo Nordisk A/S NVO | 5.57% |
| Pfizer Inc PFE | 4.55% |
| Abbvie Inc ABBV | 4.54% |
| Bristol-Myers Squibb Co BMY | 4.49% |
| Gsk Plc GSK | 4.48% |
| Johnson & Johnson JNJ | 4.43% |
| Mckesson Corp MCK | 4.42% |
Sector mix
Price chart
USD108.78
-0.02 (-0.02%)
Loading historical data…
Returns
| 1 month | +3.31% |
| 3 months | +4.77% |
| 6 months | +3.11% |
| Year to date | +5.44% |
| 1 year | +21.73% |
| 3 years (ann.) | +12.31% |
| 5 years (ann.) | +8.08% |
| 10 years (ann.) | +6.38% |
Risk profile
| Volatility (1y, ann.) | 18.14% |
| Sharpe (1y) | 1.17 |
| Sharpe (3y) | 0.82 |
| Sortino (1y) | 2.19 |
| Max drawdown (1y) | -11.49% |
| Max drawdown (5y) | -20.52% |
| Max drawdown (full) | -56.61% |
| Beta vs S&P 500 (1y) | 0.36 |
| Correlation vs S&P 500 (1y) | 0.25 |
Technical outlook as of 2026-07-13
Day Score (bias 0-100, not a probability)
56
P(gain) 22 sessions — probability
53%
VaR 95% (daily)
-1.59%
CVaR 95% (daily)
-2.50%
GARCH vol forecast (22d)
1.25%
Market regime (Markov)
Lateral
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Top-10 concentration
72.7%
Effective holdings
12
Disclosed positions
27
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Loading map…
Cost vs. peers
PPH
0.36%
Equity median
0.39%
Cheapest in class BKLC
0.00%
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-07-01 | 2026-07-07 | USD 0.6248 |
| 2026-04-01 | 2026-04-07 | USD 0.8441 |
| 2025-12-29 | 2025-12-31 | USD 0.3106 |
| 2025-10-01 | 2025-10-06 | USD 0.3931 |
| 2025-07-01 | 2025-07-07 | USD 0.6069 |
| 2025-04-01 | 2025-04-04 | USD 0.5245 |
| 2024-12-27 | 2024-12-30 | USD 0.4110 |
| 2024-10-01 | 2024-10-04 | USD 0.4090 |
| 2024-07-01 | 2024-07-05 | USD 0.3558 |
| 2024-04-01 | 2024-04-05 | USD 0.5328 |
| 2023-12-27 | 2023-12-29 | USD 0.3074 |
| 2023-10-02 | 2023-10-06 | USD 0.3398 |
| 2023-07-03 | 2023-07-07 | USD 0.3891 |
| 2023-04-03 | 2023-04-10 | USD 0.6641 |
| 2022-12-28 | 2022-12-30 | USD 0.2400 |
| 2022-10-03 | 2022-10-07 | USD 0.2696 |
| 2022-07-01 | 2022-07-08 | USD 0.2496 |
| 2022-04-01 | 2022-04-07 | USD 0.4429 |
| 2021-12-29 | 2021-12-31 | USD 0.2691 |
| 2021-10-01 | 2021-10-07 | USD 0.3453 |
| 2021-07-01 | 2021-07-08 | USD 0.2859 |
| 2021-04-01 | 2021-04-08 | USD 0.3497 |
| 2020-12-29 | 2021-01-05 | USD 0.2662 |
| 2020-10-01 | 2020-10-07 | USD 0.2493 |
| 2020-07-01 | 2020-07-07 | USD 0.2523 |
| 2020-04-01 | 2020-04-07 | USD 0.3374 |
| 2019-12-30 | 2020-01-06 | USD 0.1729 |
| 2019-10-01 | 2019-10-07 | USD 0.2920 |
| 2019-07-01 | 2019-07-08 | USD 0.2810 |
| 2019-04-01 | 2019-04-05 | USD 0.3900 |
| 2018-12-27 | 2019-01-03 | USD 0.2032 |
| 2018-10-01 | 2018-10-05 | USD 0.2345 |
| 2018-07-02 | 2018-07-09 | USD 0.2493 |
| 2018-04-02 | 2018-04-06 | USD 0.3943 |
| 2017-12-27 | 2018-01-03 | USD 0.1500 |
| 2017-10-02 | 2017-10-11 | USD 0.2210 |
| 2017-07-03 | 2017-07-10 | USD 0.3040 |
| 2017-04-03 | 2017-04-07 | USD 0.4651 |
| 2016-12-28 | 2017-01-04 | USD 0.1450 |
| 2016-10-03 | 2016-10-07 | USD 0.2150 |
Splits
| 2012-02-14 | 2:1 |
ESG profile
Derived from holdings
covers 62.1% of the portfolio by weight
(16 scored constituents)
Environmental
72.9
class avg 63.0
Social
63.8
class avg 62.3
Governance
69.4
class avg 64.9
Total ESG
68.7
class avg 63.4
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Value ETF VTV | 0.03% | 245.00B | 6.3% |
| State Street SPDR Portfolio S&P 500 ETF SPYM | 0.02% | 159.32B | 4.2% |
| iShares Core S&P 500 UCITS ETF CSSPX.MI | 0.07% | 151.54B | 4.2% |
| iShares Core S&P 500 UCITS ETF SXR8.DE | 0.07% | 151.54B | 4.2% |
| iShares Core S&P 500 UCITS ETF CSPX.L | 0.07% | 151.69B | 4.2% |
